New study aims to uncover hidden danger in kawasaki disease

NCT ID NCT07491926

Not yet recruiting Knowledge-focused Sponsor: Meyer Children's Hospital IRCCS Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will observe 150 children with Kawasaki disease to learn more about a rare but serious complication called Macrophage Activation Syndrome (MAS). Researchers will collect data on symptoms, lab results, and treatments across multiple European hospitals. The goal is to better understand how often MAS occurs, what puts children at risk, and how to diagnose it more accurately.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to identify and treat MAS in children with Kawasaki disease, potentially preventing serious complications.
What could go wrong: This is an observational study, not a treatment trial. It may not directly change care, and results depend on accurate diagnosis and data collection across many hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KAWASAKI DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Kawasaki disease macrophage activation syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KAWASAKI DISEASE MACROPHAGE ACTIVATION SYNDROME (MAS)

Contacts and locations

Locations

Azienda Ospedaliero-Universitaria IRCCS Meyer

Florence, Italy, 50139, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.